Rheumatoid Arthritis Clinical Trial
Official title:
Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer® Trabecular Metalâ„¢ Total Ankle
Verified date | May 2024 |
Source | Zimmer Biomet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objective of this study is to obtain implant survivorship and clinical outcome data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary or revision total ankle arthroplasty. The assessment will include implant survivorship and clinical performance measured by pain and function, quality of life data, radiographic parameters and survivorship.
Status | Active, not recruiting |
Enrollment | 120 |
Est. completion date | March 2027 |
Est. primary completion date | March 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - The patient is > 18 years of age - The patient is skeletally mature - The patient qualifies for primary or revision total ankle replacement based on physical exam and medical history including the following: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis. - The patient is willing and able to provide written informed consent - Patient is willing and able to cooperate in the required post-operative therapy - The patient is willing and able to complete scheduled follow-up evaluations questionnaires as described in the Informed Consent - The patient has participated in the Informed Consent process and has signed the Institutional Review Board/European Commission approved Informed Consent Exclusion Criteria: - The patient is: a prisoner, mentally incompetent or unable to understand what participation in the study entails, a known alcohol or drug abuser, anticipated to be non-compliant. - The patient has one of the following compromising the affected limb: ankle arthrodesis with malleolar exeresis, severe neurological or vascular disease, loss of musculature or neuromuscular compromise, severe instability, maltracking or misalignment of the tibia and talus uncorrectable by surgery. - The patient has a local/systemic infection that may affect the prosthetic joint - The patient has a previous history of infection in the affected joint - The patient is known to be pregnant - The patient has insufficient bone stock or bone quality to fix the components (i.e. osteoporosis, Charcot's disease) - The patient has a known sensitivity or allergic reaction to one or more of the implanted materials - The patient is unwilling or unable to give consent or to comply with the follow-up program |
Country | Name | City | State |
---|---|---|---|
Canada | UBC Providence Health Care Research Institute | Vancouver | British Columbia |
Finland | Turku University Hospital Finland | Turku | |
Germany | Klinikverbund St. Antonius und St. Josef GmbH | Wuppertal | |
Italy | Humanitas San Pio X | Milan | Milano MI |
Switzerland | Inselspital-Stiftung Universitatsspital Bern | Bern | |
Switzerland | Spital StS AG | Thun | |
United States | OrthoCarolina Research Institute | Charlotte | North Carolina |
United States | Duke University | Durham | North Carolina |
United States | Orthopaedic Associates of Grand Rapids REI | Grand Rapids | Michigan |
United States | The Rothman Institute | Philadelphia | Pennsylvania |
United States | University California Davis | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
Zimmer Biomet |
United States, Canada, Finland, Germany, Italy, Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Survivorship | Survival of the implants after 10 years which is based on removal of the prosthesis and will be determined using the Kaplan Meier Method. | 10 years | |
Secondary | American Orthopaedic Foot and Ankle Society Score | Performance os the Zimmer Trabecular Metal Ankle after 2 years which is assessed by the AOFAS score. | First 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |